Vident Advisory’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$215K Buy
3,203
+285
+10% +$20.8K ﹤0.01% 1759
2026
Q1
$223K Buy
+2,918
New +$210K ﹤0.01% 1637
2025
Q4
Sell
-19,931
Closed -$1.26M 1664
2025
Q3
$1.26M Buy
19,931
+3,283
+20% +$229K 0.01% 731
2025
Q2
$1.24M Buy
16,648
+12,852
+339% +$1.01M 0.01% 659
2025
Q1
$334K Buy
3,796
+1,251
+49% +$118K ﹤0.01% 1232
2024
Q4
$233K Buy
2,545
+78
+3% +$8K ﹤0.01% 1271
2024
Q3
$276K Buy
2,467
+251
+11% +$25.1K 0.01% 1166
2024
Q2
$217K Sell
2,216
-141,042
-98% -$14M 0.01% 1262
2024
Q1
$14.4M Buy
+143,258
New +$12.6M 0.3% 115
2023
Q4
Sell
-3,264
Closed -$250K 1330
2023
Q3
$250K Buy
+3,264
New +$271K 0.01% 1008

Other funds holding EMN

Vident Advisory's EMN Position: Q2 2026 in Review

Vident Advisory increased its Eastman Chemical (EMN) stake by 9.8% in Q2 2026, buying an estimated $20.8K and bringing the position to 3,203 shares worth $215K. The position accounts for ﹤0.01% of the portfolio, ranked #1759.

Vident Advisory first reported a position in EMN in Q3 2023 and has held it in 10 quarters since. The position peaked at $14.4M in Q1 2024. 642 funds tracked by Wall St. Rank hold EMN as of Q2 2026.

  • Vident Advisory held 3,203 shares of Eastman Chemical worth $215K as of Q2 2026.
  • Vident Advisory bought 285 Eastman Chemical shares in Q2 2026, an estimated $20.8K.
  • Eastman Chemical made up ﹤0.01% of Vident Advisory's portfolio in Q2 2026, its #1759 holding.
  • Vident Advisory first reported a position in Eastman Chemical in Q3 2023 and has held it in 10 quarters since.
  • Vident Advisory's Eastman Chemical position peaked at $14.4M in Q1 2024.
  • 642 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.